Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Shilpa Medicare

BSE: 530549|NSE: SHILPAMED|ISIN: INE790G01031|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 20, 14:57
464.90
-4.3 (-0.92%)
VOLUME 1,810
LIVE
NSE
Feb 20, 14:57
464.00
-3.45 (-0.74%)
VOLUME 18,250
Announcements on Shilpa

19th-Feb-2018 16:00Source: BSE

Shilpa Medicare- Corporate Action- Record Date For Declaration Of Interim Dividend, If Any, Is Fixed On 05Th March, 2018.

the Record Date for Declaration of Interim Dividend, if any, is fixed on 05th March, 2018.

19th-Feb-2018 15:54Source: BSE

Shilpa Medicare- Board to consider Interim Dividend

Shilpa Medicare Ltd has informed BSE that a meeting of Board of Directors will be held on February 22, 2018, inter alia, to consider, declaration of interim dividend for the financial year ending Marc...

19th-Feb-2018 15:46Source: BSE

Shilpa Medicare- Board Meeting On February 22, 2018

We wish to inform you that a meeting of Board of Directors will be held on Thursday, the 22nd day of February, 2018 to consider, inter alia, declaration of interim dividend for the financial year endi...

15th-Feb-2018 17:25Source: BSE

Shilpa Medicare- Announcement under Regulation 30 (LODR)-Newspaper Publication

We are enclosing herewith paper cuttings of the notice published in newspaper viz. Business Standard and Suddimoola (Kannada Daily) on 15th February 2018 with regard to publication of Financial Result...

13th-Feb-2018 15:11Source: BSE

Shilpa Medicare- Board Meeting-Outcome of Board Meeting

The Board in its meeting held on February 13, 2018, inter-alia, considered the following items:

1.Un-Audited Standalone and Consolidated Financial Results for the quarter ended December 31, 2...

13th-Feb-2018 14:35Source: BSE

Shilpa Medicare- Un-Audited Financial Results For The Quarter Ended December 31, 2017

We hereby submitting un-audited standalone and consolidated financial results along with the limited review report issued by auditor for the quarter ended December 31, 2017.

7th-Feb-2018 19:27Source: BSE

Shilpa Medicare- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnukant C Bhutada

1st-Feb-2018 16:13Source: BSE

Shilpa Medicare- Board Meeting On February 13, 2018.

We wish to inform you that a meeting of Board of Directors will be held on Tuesday, the 13th day of February, 2018 inter alia to consider the Un-audited Financial Results for the Third Quarter ended 3...

22nd-Jan-2018 14:42Source: NSE

Shilpa Medicare Limited

Shilpa Medicare Limited has informed the Exchange regarding ''that the US FDA has completed inspection of Company''s API facilities Unit-I and Unit-II located at Raichur, Karnataka, India which was in...

22nd-Jan-2018 14:04Source: BSE

Shilpa Medicare- Updates

This is to inform you that the US FDA has completed inspection of Company''s API facilities Unit-I and Unit-II located at Raichur, Karnataka, India which was inspected between 16th January and 19th Ja...

1 2 3 4 5 Next >>
Quick Links for Shilpa Medicare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.